Long-Acting Stimulant Pharmacotherapy Improves Academic Performance in Students with ADHD
Research has shown that long-acting stimulant pharmacotherapy has a positive impact on the academic performance of students with attention deficit hyperactivity disorder (ADHD). A study conducted by the University of New Brunswick investigated the effects of this treatment on academic outcomes among students in grades K-12. The study found that students with ADHD who received long-acting stimulant treatment showed significant improvements in report card scores, standardized assessment exam performance, and school attendance compared to their untreated peers.
Key Takeaways:
- The study examined the impact of long-acting stimulant pharmacotherapy on academic outcomes among 15,544 students with ADHD in grades K-12.
- Students with ADHD who received long-acting stimulant treatment showed significant improvements in report card scores, with a score estimate of -4.93 compared to -6.19 for untreated students.
- Long-acting stimulant treatment was also associated with improved provincial assessment exam scores, with a percentile rank estimate of -9.20 compared to -11.50 for untreated students.
- The treatment reduced absences among grades K-12, with an absence rate estimate of -3.33 compared to 7.96 for untreated students.
- Chandy Somayaji and colleagues from the University of New Brunswick found that long-acting stimulant treatment increased the likelihood of graduation and transition to post-secondary education.
- The study controlled for various confounding factors and found that long-acting stimulant treatment had a significant positive impact on academic outcomes.
Statistics:
- 15,544 students with ADHD received long-acting stimulant treatment.
- 204,681 students without ADHD served as a control group.
- 27,880 students with ADHD did not receive treatment.
- The study examined report card scores, standardized assessment exam performance, school attendance, graduation rates, and transition to post-secondary education over a period of time.
Sources:
- NewsRx. New Attention Disorders Study Results Reported from University of New Brunswick (Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management). Mental Health Weekly Digest. October 20, 2025; p 304.
- Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management. Journal of Attention Disorders, 2025:10870547251378169.
- Sage Publications Inc. Journal of Attention Disorders. 2455 Teller Rd, Thousand Oaks, CA 91320, USA. (www.sagepub.com/jad.sagepub.com)